{"nct_id":"NCT05065970","title":"Clinical Trial to Assess Efficacy and Safety of the Human Anti-CD38 Antibody Felzartamab (MOR202) in IgA Nephropathy","status":"COMPLETED","status_verified_date":"2025-02","start_date":"2021-08-31","start_date_type":"ACTUAL","primary_completion_date":"2023-02-06","primary_completion_date_type":"ACTUAL","completion_date":"2024-05-06","completion_date_type":"ACTUAL","phases":["PHASE2"],"tickers":["BIIB"]}